The DOI matches its Crossref record; 28 of the 29 references it cites were found in a registry or an index.
Efficacy and safety of methylphenidate in 45 adults with attention-deficit/hyperactivity disorder. A randomized placebo-controlled double-blind cross-over trial
Open accessAbstract
Background. Data on the efficacy and safety of methylphenidate in adults with attention deficit/hyperactivity disorder (ADHD) are lacking in Europe. This study was undertaken to report on the efficacy and safety of methylphenidate in an adult out-patient population with ADHD, and to compare results with US data. Method. A double-blind randomized cross-over trial comparing methylphenidate and placebo in 45 adults with ADHD with childhood onset was performed in a dose–titration design. Methylphenidate was titrated from 0·5 mg/kg per day in week 1 up to 1·0 mg/kg per day in week 3. Results. Response rates using methylphenidate varied between 38 and 51%, and using placebo between 7 and 18% ( p <0·05), depending on outcome measure used. Although the overall percentage of subjects having any side effect on both methylphenidate and placebo was rather high, side effects on methylphenidate over and above those on placebo were few and mild. Conclusions. Methylphenidate proves to be an effective and well tolerated treatment for symptoms of ADHD in adults in the short term. Future research should study the long-term response and clarify the impact of gender, co-morbidity, socio-economic status and IQ on response rates in adults with ADHD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Similarly in adults, co-morbidity is the rule, with 75% of clinical patients having at least one other disorder, and the mean number of psychiatric comorbidities being three [41,148].”
From European consensus statement on diagnosis and treatment of adult ADHD: The European Network Adult ADHD (2010) · cites this paper as [148]
In the citing paper
“Comorbidity being the rule rather than the exception, the evaluation of co-occurring symptoms, syndromes and disorders must always be part of the clinical assessment of adult ADHD [148,150].”
From European consensus statement on diagnosis and treatment of adult ADHD: The European Network Adult ADHD (2010) · cites this paper as [148]
In the citing paper
“Side-effects are usually mild and transitory, mainly consisting of headache, reduced appetite, palpitations, nervousness, difficulty falling asleep, and dry mouth [148,269,270].”
From European consensus statement on diagnosis and treatment of adult ADHD: The European Network Adult ADHD (2010) · cites this paper as [148]
In the citing paper
“Compliance to such frequent dosing regimens is however poor in ADHD patients due to forgetfulness, inattentiveness and self-organisation problems, leading to daily instability by frequent rebound symptoms and ineffective treatment [148,289-291].”
From European consensus statement on diagnosis and treatment of adult ADHD: The European Network Adult ADHD (2010) · cites this paper as [148]
In the citing paper
“The requirement for a longer duration of activity in adults, requires repetitive dosing with immediate release stimulants, of between three to four doses in most cases, and more often in others, to avoid rebound symptoms and for adequate control of ADHD symptoms during the day and evening [148,270].”
From European consensus statement on diagnosis and treatment of adult ADHD: The European Network Adult ADHD (2010) · cites this paper as [148]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Diagnostic and Statistical Manual of Mental Disorders
Williams, J. B. W., & First, M. B. (2013) · Oxford University Press eBooks · doi:10.1093/acrefore/9780199975839.013.104 · Cited by 109,845
Hamilton, M. (1960) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.23.1.56 · Cited by 32,817
The assessment of anxiety states by rating
HAMILTON, M. (1959) · British Journal of Medical Psychology · doi:10.1111/j.2044-8341.1959.tb00467.x · Cited by 11,455
Robins, L. N. (1988) · Archives of General Psychiatry · doi:10.1001/archpsyc.1988.01800360017003 · Cited by 2,909
(1998) · Cited by 2,026
Biederman, J. (2000) · American Journal of Psychiatry · doi:10.1176/appi.ajp.157.5.816 · Cited by 1,498
Sheehan, D. V., Harnett-Sheehan, K., & Raj, B. A. (1996) · International Clinical Psychopharmacology · doi:10.1097/00004850-199606003-00015 · Cited by 1,440
Ostwald, P. F. (1960) · American Journal of Psychotherapy · doi:10.1176/appi.psychotherapy.1960.14.4.817 · Cited by 1,422
Mannuzza, S. (1993) · Archives of General Psychiatry · doi:10.1001/archpsyc.1993.01820190067007 · Cited by 1,368
Barkley, R. A., Fischer, M., Smallish, L., & Fletcher, K. (2002) · Journal of Abnormal Psychology · doi:10.1037/0021-843x.111.2.279 · Cited by 1,199
Attention-deficit hyperactivity disorder : a clinical workbook
Barkley, R. A., & Murphy, K. R. (1991) · Cited by 1,144
(1993) · American Journal of Psychiatry · doi:10.1176/ajp.150.12.1792 · Cited by 950 · cited 2×
“ADHD in children as well as adults, is highly co-morbid (Biederman et al. 1993; Kooij et al. 2001).”
BackgroundWilens, T. E., Faraone, S. V., Biederman, J., & Gunawardene, S. (2003) · Pediatrics · doi:10.1542/peds.111.1.179 · Cited by 872
Pharmacotherapy of Attention-Deficit Hyperactivity Disorder across the Life Cycle
SPENCER, T., BIEDERMAN, J., WILENS, T., HARDING, M., O'DONNELL, D., & GRIFFIN, S. (1996) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-199604000-00008 · Cited by 830
Attention deficit hyperactivity disorder adults: Comorbidities and adaptive impairments
Murphy, K., & Barkley, R. A. (1996) · Comprehensive Psychiatry · doi:10.1016/s0010-440x(96)90022-x · Cited by 700
Barkley, R. A., McMurray, M. B., EDELBROCK, C. S., & Robbins, K. (1990) · PubMed · Cited by 433
Spencer, T. (1995) · Archives of General Psychiatry · doi:10.1001/archpsyc.1995.03950180020004 · Cited by 402
Prevalence of DSM-IV symptoms of ADHD in adult licensed drivers: Implications for clinical diagnosis
Murphy, K., & Barkley, R. A. (1996) · Journal of Attention Disorders · doi:10.1177/108705479600100303 · Cited by 376
Neuropsychological function in adults with attention-deficit hyperactivity disorder
Seidman, L. J., Biederman, J., Weber, W. J., Hatch, M., & Faraone, S. V. (1998) · Biological Psychiatry · doi:10.1016/s0006-3223(97)00392-2 · Cited by 285
Spencer, T., Biederman, J., Wilens, T., Faraone, S., Prince, J., Gerard, K., Doyle, R., Parekh, A., Kagan, J., & Bearman, S. K. (2001) · Archives of General Psychiatry · doi:10.1001/archpsyc.58.8.775 · Cited by 250 · cited 1×
“Higher dosing of stimulants results in more robust responses (Spencer et al. 2001).”
Adults with attention-deficit/hyperactivity disorder: a controversial diagnosis.
Spencer, T. J., Biederman, J., Wilens, T. E., & Faraone, S. V. (1998) · PubMed · Cited by 179
Milberger, S., Biederman, J., Faraone, S. V., Wilens, T., & Chu, M. P. (1997) · American Journal on Addictions · doi:10.3109/10550499709005063 · Cited by 113
Attention deficit hyperactivity disorder in childhood among adults with major depression
Alpert, J. E., Maddocks, A., Nierenberg, A. A., O'Sullivan, R., Pava, J. A., Worthington, J. J., Biederman, J., Rosenbaum, J. F., & Fava, M. (1996) · Psychiatry Research · doi:10.1016/0165-1781(96)02912-5 · Cited by 108
Rapport, M. D., Jones, J. T., DuPaul, G. J., Kelly, K. L., Gardner, M. J., Tucker, S. B., & Shea, M. S. (1987) · Journal of Clinical Child Psychology · doi:10.1207/s15374424jccp1604_6 · Cited by 91
Psychopharmacology of ADHD: children and adolescents.
Findling, R. L., & Dogin, J. W. (1998) · PubMed · Cited by 89
Kooij, J. J. S., Aeckerlin, L. P., & Buitelaar, J. K. (2001) · PubMed · Cited by 63
Self-citationFones, C. S. L., Pollack, M. H., Susswein, L., & Otto, M. (2000) · Journal of Affective Disorders · doi:10.1016/s0165-0327(99)00065-8 · Cited by 47
McNemar, Q. (1974) · Journal of Consulting and Clinical Psychology · doi:10.1037/h0035842 · Cited by 29
Research works printed but not linked: 3
- Barkley, R. A. (1990). Attention-Deficit Hyperacitivity Disorder. A Handbook for Diagnosis and Treatment. The Guilford Press : New York.
- NIMH (1985). CGI (Clinical Global Impression) Scale. Psycho- pharmacology Bulletin 21, 839-844.
- Prince, J. & Wilens, T. (2002). Medications used in the treatment of AD/HD in women. In Gender Issues and AD/HD (ed. P. Quinn and K. Nadeau), pp. 144-182. Advantage Books : Silver Spring.
Cited by
Sorted by citations
Kooij, S. J., Bejerot, S., Blackwell, A., Caci, H., Casas-Brugué, M., Carpentier, P. J., Edvinsson, D., Fayyad, J., Foeken, K., Fitzgerald, M., et al. (2010) · BMC Psychiatry · doi:10.1186/1471-244x-10-67 · Cited by 928
“Side-effects are usually mild and transitory, mainly consisting of head-ache, reduced appetite, palpitations, nervousness, difficulty falling asleep, and dry mouth [148,269,270].”
InfluentialSandra Kooij, J. J., Marije Boonstra, A., Swinkels, S. H. N., Bekker, E. M., de Noord, I., & Buitelaar, J. K. (2008) · Journal of Attention Disorders · doi:10.1177/1087054707299367 · Cited by 388
“However, because patients had participated in a medication study (Kooij et al., 2004) or in a study investigating event related potentials (ERP; Bekker et al., 2006) after they had been diagnosed, the following exclusion criteria were used: presence of cardiac disease, high blood pressure,…”
BackgroundMethodInfluentialSelf-citationFaraone, S. V., & Glatt, S. J. (2010) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.08m04902pur · Cited by 387
Sobanski, E., Brüggemann, D., Alm, B., Kern, S., Deschner, M., Schubert, T., Philipsen, A., & Rietschel, M. (2007) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-007-0712-8 · Cited by 378
Psychiatric comorbidity in adults with attention-deficit/hyperactivity disorder (ADHD)
Sobanski, E. (2006) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-006-1004-4 · Cited by 340
Metadata
- Authors
- KOOIJ, J. J. S., BURGER, H., BOONSTRA, A. M., VAN DER LINDEN, P. D., KALMA, L. E., & BUITELAAR, J. K.
- Affiliations
- Radboud University Medical Center (NL)
- Venue
- Psychological Medicine
- Publisher
- Cambridge University Press (CUP)
- Published
- 2004-08
- Volume
- 34
- Issue
- 6
- Pages
- 973-982
- ISSN
- 0033-2917 (ISSN-L)
- 1469-8978
- OpenAlex
- W2093719531
- Cited by
- 163
- References
- 29
- Citations by year
- 2026: 1 · 2025: 2 · 2024: 2 · 2022: 1 · 2021: 7 · 2020: 5 · 2019: 5 · 2018: 1 · 2017: 1 · 2016: 6 · 2015: 8 · 2014: 10 · 2013: 12 · 2012: 13
- FWCI
- 7.67
- Type
- journal article
- Language
- en
- Open access
- green
- hdl.handle.net
- Locations
- Psychological Medicine (publishedVersion)
- PubMed (publishedVersion)
- EUR Research Repository (Erasmus University Rotterdam) (publishedVersion)
- Digital Academic REpository of VU University Amsterdam (Vrije Universiteit Amsterdam) (submittedVersion)
- VU Research Portal (submittedVersion, other-oa)
- EUR Research Repository (Erasmus University Rotterdam) (submittedVersion)
- University of Groningen research database (University of Groningen / Centre for Information Technology) (submittedVersion, other-oa)
- Radboud Repository (Radboud University) (submittedVersion)
- Data Archiving and Networked Services (DANS) (submittedVersion, other-oa)
- Funders
- Hersenstichting
- Nationaal Fonds Geestelijke Volksgezondheid
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Attention Deficit Hyperactivity Disorder
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Keywords
- methylphenidate, adult ADHD, ADHD medication, dose titration, treatment efficacy, drug safety, adverse effects, childhood-onset ADHD, outpatients
- MeSH terms
- Adult, Central Nervous System Stimulants, Attention Deficit Disorder with Hyperactivity, Double-Blind Method, Female, Humans, Male, Methylphenidate, Middle Aged, Placebos, Treatment Outcome, Cross-Over Studies
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
